Operose Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-43
Closed -$15.5K – 618
2024
Q3
$15.5K Hold
43
– – 0.01% 434
2024
Q2
$14.6K Sell
43
-35
-45% -$11.9K 0.01% 392
2024
Q1
$27.9K Hold
78
– – 0.01% 331
2023
Q4
$23.4K Sell
78
-65
-45% -$18.2K 0.01% 338
2023
Q3
$39.1K Buy
143
+108
+309% +$31K 0.02% 356
2023
Q2
$10.7K Hold
35
– – ﹤0.01% 277
2023
Q1
$9.99K Hold
35
– – 0.01% 267
2022
Q4
$8.56K Hold
35
– – ﹤0.01% 290
2022
Q3
$7K Sell
35
-70
-67% -$14.7K ﹤0.01% 294
2022
Q2
$21K Hold
105
– – 0.01% 199
2022
Q1
$28K Hold
105
– – 0.02% 190
2021
Q4
$28K Buy
+105
New +$27.6K 0.02% 178

Other funds holding SYK

Operose Advisors's SYK Position: Q4 2024 in Review

Operose Advisors sold out of Stryker (SYK) in Q4 2024, closing a stake of 43 shares — an estimated $15.5K sold.

Operose Advisors first reported a position in SYK in Q4 2021 and held it in 12 quarters. The position peaked at $39.1K in Q3 2023. 2,201 funds tracked by Wall St. Rank hold SYK as of Q4 2024.

  • Operose Advisors reported no remaining Stryker position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 43 Stryker shares in Q4 2024, an estimated $15.5K.
  • Operose Advisors first reported a position in Stryker in Q4 2021 and held it in 12 quarters.
  • Operose Advisors's Stryker position peaked at $39.1K in Q3 2023.
  • 2,201 funds tracked by Wall St. Rank held Stryker as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.